| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |